ANTX Stock Analysis: Buy, Sell, or Hold?
ANTX - AN2 Therapeutics, Inc. Common Stock
$4.60
0.00 (0.00%)
▲
5d:
-1.71%
30d:
+50.82%
90d:
+322.02%
HOLD
MODERATE Confidence
Analysis Updated: May 7, 2026 12:00 AM ET
Earnings: May 12, 2026
3d
Get Alerted When ANTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ANTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ANTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ANTX is currently trading at $4.60, which is considered extended relative to its 30-day fair value range of $3.21 to $4.55.
Technical Outlook: Technically, ANTX is in a strong uptrend. Immediate support is located at $4.01, while resistance sits at $5.17.
Market Sentiment: ANTX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $1.00. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ANTX is in a strong uptrend. Immediate support is located at $4.01, while resistance sits at $5.17.
Market Sentiment: ANTX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $1.00. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.21 -
$4.55
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 78.3% above Wall St target ($1.00)
Trading Range Analysis
30-Day Trading Range
$3.21 -
$4.55
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$4.01
Resistance Level
$5.17
Current Trend
Strong Uptrend
Technical data as of
May 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.75
Wall Street Target
$1.00
(-78.3%)
Share & Embed Analysis
Last updated: May 08, 2026 10:17 AM ET
Data refreshes hourly during market hours. Next update: 11:17 AM
Data refreshes hourly during market hours. Next update: 11:17 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ANTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
Sarah Joanne Williams
SELL
327 shares
2026-03-03
Joshua M Eizen
SELL
6931 shares
2026-01-06
Lucy Day
SELL
5512 shares
2026-01-06
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$90 | 56 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$93 | 67 BUY |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
BHVN
Biohaven Pharmaceutical … |
STRONG BUY
16 analysts |
$22 | 57 HOLD |
|
RVMD
Revolution Medicines Inc |
STRONG BUY
12 analysts |
$174 | 63 BUY |
